The panel is designed to identify 13 common bacterial and viral respiratory pathogens from one nasopharyngeal swab.

Cepheid, a Danaher company, today announced it has donated an initial shipment of Xpert® Hemorrhagic Fever panel tests to support the diagnostic response to the Ebola Bundibugyo (BDBV) outbreak in the ...

Cepheid, a Danaher company, announced today that it has received FDA clearance for the Xpert Respiratory Panel, a multiplex PCR test designed to detect 13 common viral and bacterial respiratory ...

SUNNYVALE, Calif. , Feb. 18, 2026 /PRNewswire/ -- Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators ...

Though the global number of recorded monkeypox cases continues to climb—passing 4,100 last week, according to the Centers for Disease Control and Prevention (CDC)—many researchers and epidemiologists ...

The collaboration will focus on in vitro diagnostics for Cepheid’s GeneXpert platform, starting with a proof-of-concept project aimed at the novel coronavirus. (Ernesto del Aguila III, NIH NHGRI) ...

SUNNYVALE, Calif., Dec. 8, 2022 /PRNewswire/ -- Currently circulating mutant strains of influenza highlight the need for multi-target diagnostic tests. Two recently identified mutations in the matrix ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...